| # | Drug | Count |
|---|---|---|
| 0 | MYCOPHENOLATE MOFETIL | 19 |
| 1 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 19 |
| 2 | TACROLIMUS | 17 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 15 |
| 4 | TACROLIMUS OINTMENT 0.1% | 15 |
| 5 | PREDNISONE | 8 |
| 6 | BASILIXIMAB | 7 |
| 7 | METHYLPREDNISOLONE | 7 |
| 8 | FAMOTIDINE | 3 |
| 9 | FEBUXOSTAT | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BASILIXIMAB | 7 | 0.0006 |
| 1 | AMPHOTERICIN B LIPOSOME | 1 | 0.0004 |
| 2 | FEBUXOSTAT TABLETS 40 MG | 3 | 0.0003 |
| 3 | AVELUMAB | 1 | 0.0002 |
| 4 | FEBUXOSTAT | 3 | 0.0002 |
| 5 | MYCOPHENOLATE MOFETIL | 19 | 0.0001 |
| 6 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 19 | 0.0001 |
| 7 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 1 | 0.0001 |
| 8 | SEVOFLURANE | 1 | 0.0001 |
| 9 | TACROLIMUS OINTMENT 0.1% | 15 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antimetabolite Immunosuppressant [EPC] | 2 | 0.0001 |
| 1 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0001 |
| 2 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 3 | Penem Antibacterial [EPC] | 2 | 0.0001 |
| 4 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 5 | Polyene Antifungal [EPC] | 2 | 0.0000 |
| 6 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 7 | Oxazolidinone Antibacterial [EPC] | 1 | 0.0000 |
| 8 | General Anesthetic [EPC] | 1 | 0.0000 |
| 9 | Histamine-2 Receptor Antagonist [EPC] | 3 | 0.0000 |